EXAS Exact Sciences Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
12:00
Apr 21
Apr 21
Cancer screening companies are growing rapidly.
Companies like Exact Sciences and Guardant Health are advancing colorectal cancer screening with stool-based and blood tests, respectively, making screening more convenient and increasing adoption. Blood tests are inflecting and multi-cancer early detection tests are emerging, which could lead to earlier cancer detection and better outcomes.
HIGH
About EXAS Analyst Coverage
Buzzberg tracks EXAS (Exact Sciences) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Latest voices: Alex Karnal.